New SEC Form D filing

Immorta Bio, Inc., 2026-10-16

A new SEC Form D private-offering notice from Miami Beach, FL, a $5,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Immorta Bio, Inc. site↗ Verified via SEC Form D

Biotechnology company developing senolytic immunotherapies and personalized stem cell regenerative treatments for diseases of aging

Filed 7 days agoFiled to raise $5,000,000First money in 2024-11-05Raised so far $612,503HQ (as filed) Miami Beach, FLSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Late filing
Source linked the Form D on EDGAR↗Website verified immortabio.com↗Named in the filing 1 executive & director

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source